Instituto de Biología Molecular y Celular del Cáncer de Salamanca
- Research works
- 1 ▼ 62% vs 2013–17
- Citations
- 186 209.0 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 28% world 28%
Not ranked overall: Instituto de Biología Molecular y Celular del Cáncer de Salamanca is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Instituto de Biología Molecular y Celular del Cáncer de Salamanca publish most on?
By volume in 2022–2025: Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments and Histone Deacetylase Inhibitors Research.
- 1 Protein Degradation and Inhibitors Molecular Biology 0 works
- 2 Multiple Myeloma Research and Treatments Hematology 0 works
- 3 Histone Deacetylase Inhibitors Research Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Instituto de Biología Molecular y Celular del Cáncer de Salamanca's research output changed?
Output in 2018–2022 was 62% lower than in 2013–2017.
Other research institutions in Salamanca
- Instituto de Neurociencias de Castilla y León
- Instituto Universitario de Ciencias de la Educación
- Instituto Universitario de Integración en la Comunidad
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.